Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Blue Energy Ord Shs T.BLU


Primary Symbol: BUENF

Blue Energy Limited is an Australia-based oil and gas exploration company. The Company is engaged in the exploration, evaluation and development of conventional and unconventional oil and gas resources. Its geographical segment is Australia, which includes Queensland and the Northern Territory. The Company’s projects include Bowen Basin (ATP814P), Carpentaria Basin (ATP1112A), Galilee Basin (ATP813P), South Georgina Basin (ATP1114A, ATP1117A and ATP1123A), Surat Basin (ATP854P) and Greater McArthur Basin (EP199A, EP200, EP205A, EP206, EP207, EP208A, EP209A, EP210A and EP211A). ATP814P consists of six disconnected blocks in the North Bowen Basin in an area ranging from south of Moranbah up to Newlands in the Northern Bowen Basin. ATP1112A is located in the Carpentaria Basin of northwestern Queensland. It is located south of the Gulf of Carpentaria region and approximately 40 kilometers (km) west of Normanton. ATP813P covers a large area in the Galilee Basin in Central West Queensland.


OTCPK:BUENF - Post by User

Bullboard Posts
Post by valueplaysonlyon Sep 24, 2013 3:08pm
111 Views
Post# 21764025

Added another 50 000

Added another 50 000
This is the best value play in the drug space in the free world.  It has nothing to do with the GOLDEN CROSS,    screw  the technicals, this is  GOLDEN  OPPORTUNITY.  Worth  1.25   right now     ,  this is  trading at one third    its fair market value. No  other drug company is worth less  market cap  with   2 strong phase 3 trials   in the next two    years coming,  NONE!
Bullboard Posts